Clinical Trial Update: Preemptive Analgesia Following Uterine Artery Embolization [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating preemptive analgesia after uterine artery embolization for uterine fibroids was terminated, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Fibroids

Snippet

Sponsor: Northwestern University | Conditions: Uterine Fibroids, Uterine Artery Embolization | Phase 4 | Status: TERMINATED | Results posted: 2014-09-18